Benzinga | Aug 2, 2021 07:31AM EDT

Raymond James Upgrades Encompass Health to Strong Buy, Raises Price Target to $107

Raymond James analyst John Ransom upgrades Encompass Health (NYSE:EHC) from Outperform to Strong Buy and raises the price target from $95 to $107.